Chibuzo Obi

Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States

K. Abuabara, Christopher G. Bunick, Lara Wine Lee, Ayman A. Grada et autres

BACKGROUND: Atopic dermatitis (AD) disproportionately affects diverse patient populations, and complex factors influence access to treatment among different racial and ethnic groups. OBJECTIVE: This study aimed to assess racial and ethnic differences in AD severity and access to treatment in clinical practice. …

Skin Clearance and Itch Relief in Black or African American Patients with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib: 140-Week Outcomes from Integrated Phase 3 Measure Up 1 and 2 Studies

Andrew F Alexis, Adam Friedman, Nada Elbuluk, Karan Lal et autres

Background: Clinical phenotypes and endotypes of atopic dermatitis (AD) may vary across diverse populations. Although Black or African American patients exhibit a high overall burden of disease, an evidence gap remains in understanding outcomes of advanced therapies in this population. Objectives: To …

us (code pays fourni par la source)

Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry

Jonathan I. Silverberg, Brian Calimlim, Ayman A. Grada, Christopher G. Bunick et autres

In atopic dermatitis (AD), the real-world impact of achieving itch and skin lesion treatment targets compared to partial improvement remains unclear. We assessed the relationship between itch relief (reduction in Worst Itch Numeric Rating Scale [WI-NRS]) and skin clearance (Investigator Global Assessment …

us, ca (code pays fourni par la source)

Why Do Optimal Targets for Itch and Skin Clearance Matter in Atopic Dermatitis Treatment? Insights from TARGET-DERM AD Registry

Jonathan I. Silverberg, Christopher G. Bunick, Brian Calimlim, Ayman A. Grada et autres

Introduction/Background: Atopic dermatitis (AD) patients undergoing treatment may only experience partial improvement in itch and skin lesions, often leading to suboptimal outcomes. The Aiming High in Eczema/Atopic Dermatitis (AHEAD) treat-to-target recommendations emphasize the importance of achieving optimal treatment targets, such as complete …

us (code pays fourni par la source)

709 - Greater levels of itch relief and skin clearance correlate with improved patient outcomes in atopic dermatitis – real-world insights from TARGET-DERM AD

Jonathan I. Silverberg, Keith D. Knapp, Breda Muñoz, Julie M. Crawford et autres

Abstract Introduction/Background Atopic dermatitis (AD) patients undergoing treatment may only experience partial improvements in their itch and skin lesions. However, partial improvement may not translate into optimal patient outcomes. There is limited evidence describing the impact of achieving higher efficacy measures in …

us (code pays fourni par la source)

422 Healthcare disparities in atopic dermatitis: insights from TARGET-DERM registry

Lara Wine Lee, Keith D. Knapp, Breda Muñoz, Anthony Perez et autres

Abstract Atopic dermatitis disproportionately affects diverse patient populations. Furthermore, complex factors may influence the burden of disease and access to treatment amongst different racial and ethnic groups. The aim of this study is to evaluate health disparities and real-world management patterns in …

us (code pays fourni par la source)

Resistant Sphingobacterium multivorum Bacteremia—a Case Report

Divita Singh, Nkemjika Okany, Chibuzo Obi

us (code pays fourni par la source)

The impact of the COVID-19 pandemic on UK medical education. A nationwide student survey

Nicholas Pari Tekkis, Damir Rafi, Sam Brown, Alona Courtney et autres

Dear EditorThe COVID-19 pandemic had a significant impact on the delivery of medical education across the UK, with the majority of face-to-face teaching cancelled during the first wave, and medical...

gb (code pays fourni par la source)